PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2018

PEGylated IL-11 (BBT-059): A Novel Radiation Countermeasure for Hematopoietic Acute Radiation Syndrome.

Mouse / Radiation

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 29787432 ↗2018Reported benefit

PEGylated IL-11 (BBT-059): A Novel Radiation Countermeasure for Hematopoietic Acute Radiation Syndrome.

MouseRadiationCD2F1maleSubcutaneous0.3 mg/kg single dose for efficacy studies; 1.2 mg/kg singl…24 h before, 4 h after, or 24 h after total-body irradiation

Model: Cobalt-60 gamma total-body irradiation at lethal doses (haematopoietic acute radiation syndrome)

A single 0.3 mg/kg subcutaneous dose given 24 h before, 4 h after or 24 h after irradiation raised survival to 70 to 100 per cent after lethal irradiation, with pre-administration at minus 24 h giving significantly higher survival than dosing at 24 h after irradiation. Pretreated animals showed acc…

Extraction: extract · Supplied extraction confidence: 0.75. Machine-extracted fields require source verification.